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Abstract
Human aging is associated with loss of function and regenerative capacity. Human bone marrow derived mesenchymal
stromal cells (hMSCs) are involved in tissue regeneration, evidenced by their capacity to differentiate into several lineages
and therefore are considered the golden standard for cell-based regeneration therapy. Tissue maintenance and
regeneration is dependent on stem cells and declines with age and aging is thought to influence therapeutic efficacy,
therefore, more insight in the process of aging of hMSCs is of high interest. We, therefore, hypothesized that hMSCs might
reflect signs of aging. In order to find markers for donor age, early passage hMSCs were isolated from bone marrow of 61
donors, with ages varying from 17–84, and clinical parameters, in vitro characteristics and microarray analysis were assessed.
Although clinical parameters and in vitro performance did not yield reliable markers for aging since large donor variations
were present, genome-wide microarray analysis resulted in a considerable list of genes correlating with human age. By
comparing the transcriptional profile of aging in human with the one from rat, we discovered follistatin as a common
marker for aging in both species. The gene signature presented here could be a useful tool for drug testing to rejuvenate
hMSCs or for the selection of more potent, hMSCs for cell-based therapy.
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Introduction
The average human life span has been increasing over the last
decades, mainly due to the continuous advances in medical
research but also due to the improvements of general life
conditions. Unfortunately, human aging is associated with disease,
loss of regenerative capacity and loss of function and, therefore,
there has been an increasing crisis in organ transplantation but
also in elderly-related diseases like Parkinson and Alzheimer. Also
concomitant with an increasing aging of the population, elderly-
related bone fractures increased significantly and since there is an
evident loss of bone regenerative capacity with age, the amount of
patients which will potentially benefit from stem cell based
therapies keeps on increasing, which strengthens the need for
further investigation on age-related differences in stem cell
capacity. Focus has therefore, been placed in cell-based regener-
ative therapies, with stem cells as potential sources, with the hope
to repair, restore or reduce these pathologies. Among stem cells,
human mesenchymal stromal cells have been considered as the
gold standard for cellular therapy. Not only because they are
multipotent [1], easy to isolate and can be expanded in vitro, but
also because they secrete trophic and immunomodulatory factors,
giving them therapeutic qualities and making them more
appropriate for allogeneic transplantation [2]. Furthermore,
hMSCs have established their value in clinical trials [3,4] and
several others are currently being undertaken. Tissue maintenance
and regeneration is dependent on stem cells and therefore, any loss
in number or functionality due to aging will likely have a profound
effect on our regenerative capacity [5].
Recently, Zhuo et al. found an equal contribution of donor age
and recipient age to the efficacy of rat MSC-based therapy, with
an overall decline in efficacy with age of the donor and the
recipient, suggesting stem cells are indeed influenced by the
process of aging [6,7]. For muscle, on the other hand, the age of
the microenvironment and niche, in which progenitor cells reside,
has a far greater influence than the intrinsic proliferative potential
of the progenitor cells. Loss of regeneration in muscle is, at least
partly, due to loss of Notch signaling, which could be restored by
exposure of progenitor cells to a young microenvironment [8]. For
MSCs the niche they reside in, the bone marrow, is less well-
defined and little is known about the effect of aging on this
microenvironment. The bone marrow is a complex three-
dimensional structure comprising of hematopoietic cells, MSCs,
adipocytes, endothelial cells and pericytes, all of which are
influenced by aging [9]. Since MSCs interact with several cell
types including hematopoietic cells (HSCs), which were reported
to be required to stimulate MSCs colony formation [10], it is
important to consider that age-related changes in HSCs [11]
might impact MSC function as well.
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An important aspect is then to determine whether MSCs are
aging themselves (intrinsic aging) or whether it is the environment
that is causing them to senesce by not providing the right signals
(extrinsic aging). Since MSCs reside in a very complex environ-
ment and since most of the bone marrow niche components
(matrix, HSCs, and other cells) show age-related changes [9], all
these factors can easily interfere with the biological properties of
MSCs.
Understanding the molecular pathways involved in aging is
crucial and will help in the development of cell-based regeneration
strategies.
Since different species age at different rates and possess distinct
maximum lifespan, at least part of the process of aging is suggested
to be controlled by gene expression. Human lifespan, determined
by genetics and external factors such as injuries and lifestyle, is
thought to be inheritable for up to 25% [12]. Lifespan in
centenarians has an even larger genetic component [13,14]. With
microarray techniques improving in specificity and accuracy,
extensive gene studies become of high interest in the search for
markers for aging and the understanding of the genetics behind
the process. The accumulation of DNA damages has been
introduced as a cause of loss of multipotency of hMSCs in vitro
[15]. Moreover, we and others reported on defects in DNA repair
pathways which have been associated with premature aging and
reduced longevity in mice with a genetic mutation similar to the
human disorder trichothiodystrophy (TTD) [16]. However, the
link between in vitro senescence and in vivo aging remains unclear.
While some authors have already correlated various tissue-
specific gene expression profiles with aging, such as: human brain
[17], human muscle [18] or human kidney [19] and some aging
patterns are similar between human tissues, much of it is tissue
specific [18]. Therefore, in this study we searched for general
markers of aging. Here, we present a molecular signature of
human aging by performing a genome-wide gene expression
analysis in human MSCs as a function of the age of the donors.
Moreover, we compared the performance of these aging markers
in both aging human and rat MSCs. We furthermore evaluated if
these markers obtained also reflected the process of in vitro aging.
Results
Correlation of biological characteristics and donor age
In order to identify molecular markers of the aging process
which could provide insights into the molecular mechanism that
ultimately limits human lifespan, we have isolated hMSCs from
bone marrow of 61 healthy donors to 84 years, with an average of
55 years. The distribution of age, sex and locations of aspiration
can be found in Figure 1. The aspirates were put in culture and the
cells were identified according to the set of standards proposed by
the Mesenchymal and Tissue Stem Cell Committee of the ISCT
[20]. Cells were adherent and over 94% expressed CD73 and
CD90, 60% expressed CD105, and less than 2% were CD45,
CD34, CD11b, CD19 and HLA-DR positive, as determined by
flow cytometry in cells from 3 different donors (data not shown).
We started by examining whether several biological character-
istics, such as population doublings, total yield and differentiation
capacity of the hMSCs correlated to donor age. The relation
between these parameters and donor age were evaluated with
Pearson correlations (Table 1; the correlation value is given by the
value of R). The data indicates that no strong correlations were
identified among the biological characteristics and donor age.
Most parameters, such as the number of population doublings
between day 0 and day 1 (Figure 2A), did not correlate with donor
age. While only the expression of the early osteogenic marker,
Alkaline Phosphatase (ALP), did show a slight negative correlation
(P,0.05) with donor age, for both the mean expression (Figure 2B)
and the percentage of positive cells (Figure 2C), this was mainly
due to high expression of ALP in a number of young donors.
However, when the osteogenic differentiation capacity was
assessed by determining the potency of dexamethasone to induce
ALP expression, no correlation was found.
Genetic markers for donor age
Since gene expression is altered with cellular senescence and
since it is currently unknown the extent to which age regulation of
gene expression is specific to a particular tissue or common across
many, we ought to find whether the gene expression profiles of 61
human bone-marrow-derived hMSCs correlated with the age of
their donors. Since stem cells are involved in the regenerative
process, which is lost during age, it is likely that hMSCs will also
reflect changes during the aging process as well. To perform this
genome-wide gene expression analysis, RNA was isolated from
undifferentiated hMSCs (passage 2) and hybridized to Human
Genome U133A 2.0 Arrays (Affymetrix) comprising of 22,277
probe sets representing 18,400 gene transcripts and variants.
During statistical processing, probe sets with sufficient difference in
expression (standard deviation across all donors .0.4) were
selected. Within the resulting 1653, the correlation between probe
sets and donor age was assessed using ANOVA with correction for
sex and aspiration site. P values were determined by permutation
tests omitting the seven donors from which the aspiration site is
‘‘unkown’’ and false discovery rates were calculated. The probe
sets were ranked by significance and the top 70 genes (p,0.01) are
listed in Table 2. As an example: gene number 70 in this list
(FADS1, fatty acid desaturase 1) has a false discovery rate of 0.228
(22.8%) meaning that one can expect a little over 15 genes in this
list to be false positive. In addition, this gene has a fold change of
20.012, corresponding to a fold change of 21,2 per 100 years of
donor age. We furthermore explored this list of genes by
evaluating the enriched gene ontology categories, presented in
Table 3. Remarkably, biological process associated GO terms
related to neuronal functioning were overrepresented. The
‘‘Extracellular region’’ was the only cellular component related
term enriched.
To further verify our findings, quantitative polymerase chain
reaction (qPCR) was used to validate the gene expression of 12
genes in a selection of 20 donors from the total donor bank. These
12 genes (Table 4) were selected based on an earlier gene list,
which was not yet filtered on standard deviation, nor corrected for
sex or aspiration site. We used 10 male and 10 female donors, with
5 young and 5 old donors for each sex that were selected
randomly.
Of the 12 tested genes, 6 appear in the current top list (Table 2).
The qPCR validation showed that 5 of those 6 genes were
significant, and 2 nearly significant. A further extension of the
qPCR testing to the full donor bank (61 donors) did show these
latter 2 genes (Fibroblast growth factor receptor 2, FGFR2 and Slit
homolog 3, SLIT3) also to be significant (Figure 3). Of the 6 of 12
genes that are not in the current top list, 5 were removed by the
standard deviation filtering. Of these genes, only 1 (ZNF 395)
proved to be significant (note that the standard deviation filtering
was decided on completely independent of the qPCR results).
Indeed, the qPCR results did show that ZNF395 had a nearly flat
correlation curve, especially when compared to collectin sub-
family member 12 (COLEC12), which showed a 5-fold decrease in
expression with age. The one remaining gene of the 6 genes not in
Table 2, Homeobox B7 (HOXB7), was also not validated in the
qPCR results. This gene was shown to actually correlate to the
MSC Gene Signature for Donor Age
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aspiration site (p-value 0,0002), and was removed from the top list
by correcting it for aspiration location and sex. Homeobox B7
(HOXB7) was initially on the correlation list, but did not correlate
with donor age based on the qPCR results. Based on the corrected
correlation analysis, the expression of HOXB7 was observed to be
correlating to aspiration site and after correcting the ANOVA for
aspiration site and sex, this gene was located at position 181 in the
correlation list.
This correction was performed using multiple regression
analysis, as depicted in Figure 1. For this, the following equation
(Eq. 1) was used as described previously [19]:
Yij~b0jzb1jAgeizb2jGenderizb3jLocationizeij
Although slightly different trends were observed in hMSCs
obtained from male and female, gene expression of COLEC12,
Collagen type XIII a1 (COL13A1), FGFR2, Follistatin (FST), SLIT3
and ZNF395, solely, correlated with donor age (p,0.05). For these
genes, correlation with age also gave p-values,0.05 when tested
separately on hMSCs obtained from the acetabulum, as well as
when tested on hMSCS obtained from the iliac crest. The
expression of jagged-1 (JAG1) on the other hand, was significantly
higher in hMSCs obtained from the acetabulum compared to
hMSCs from the iliac crest. Concurrently, we only saw a
significant correlation with age in the iliac crest (p-value 0.007),
and not in the acetabulum (p-value 0.208). Multiple regression
analysis was used to combine these seven genes in a general model
for donor age according to the following equation (Eq. 2):
Yij~b0jzb1jJAG1izb2jCOL13A1izb3jSLIT3iz
b4jZNF395izb5jCOLEC12iz
b6jFSTizb7jFGFR2izeij
An R was reached of 0.673. When a small data set is used, the R2
has to be corrected, resulting in an adjusted R2. In this case the
adjusted R2 is 0.381, in other words, 38.1% of the variance of
donor age is explained by the combination of these seven genetic
markers.
Correlation of gene expression with in vitro senescence
An important question remaining is whether in vitro senescence
of hMSCs reflects in vivo aging. It has been shown that long term in
vitro expansion of hMSCs leads to senescence and that this process
was associated with the accumulation of DNA damage [15], which
is also associated to premature aging in vivo [16]. Since it is
fundamental for the clinical application of hMSCs to have cells
with high differentiation potential and with the least signs of aging,
we investigated whether the genetic markers we discovered for in
vivo aging, simultaneously were relevant for in vitro aging.
Therefore, we performed qPCR on RNA isolated from hMSCs
that have been serially expanded in vitro (3 donors, passage 0–7).
Unfortunately, for the four genes we examined (with correlation p
value,0.01 in the qPCR validation), consistent trends could not
be determined (Figure 4). For FST, for example, its expression in
D.024 shows a clear negative relation to passage number,
however, this could not be confirmed in the other two donors.
Correlation of gene expression and age in rat MSCs
To validate if the genes we found are correlated to the
mechanisms of aging in different species, we investigated their
expression also in rat bone marrow stromal cells. To determine if
these genetic markers could be used as markers of aging inter-
species, we isolated MSCs from femora of young (1 month), adult
(12 months) and old (24 months) Wistar rats. We have performed
qPCR on four genes that were confirmed by qPCR to be
significantly correlated with age (p,0.01). The age-related
expression of COL13A1, JAG1 and ZNF395 could not be verified
in rat MSCs. However, the expression of FST was significantly
higher in MSCs from young rats than in old rats (Figure 5),
consistent with our finding in human MSCs.
Discussion
Aging is characterized by a series of progressive changes often
associated with increased loss of tissue function and leading to
increased risk of mortality. Many age-related changes are already
described such as hair loss, decreased respiratory and kidney
function, and decreased tissue regeneration which leads, for
example, to an increased wrinkling of the skin. A single overall
mechanism that gradually reduces functional capacity has not yet
been identified even though the process of aging is likely to be
Figure 1. Distribution of the donor population. A) The distribution of sex with age and B) the distribution of site of aspiration with age.
doi:10.1371/journal.pone.0042908.g001
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genetically controlled by a small set of genetic mechanisms [21].
But if it is true that aging has a strong genetic component, it is also
true that individual aging is subject to external influences as well.
Stem cells are thought to be in the base of tissue regeneration by
giving rise to progenitor cells that can differentiate and replace
damaged cells and therefore delaying the onset of aging.
In this study, the first step taken in the search for a marker for
aging was to evaluate whether chronological age had an effect on
stem cells differentiation potential and proliferation capacity. For
this, several biological parameters were then analyzed (Table 1)
and correlated to age (e.g. population doublings per day in
different passages, bone formation, ALP expression, adipogenesis,
etc.). Most of these parameters did not correlate with age, except
for the expression of bone-specific ALP (basic medium, P,0.05).
This was mainly due to high expression of ALP in a number of
young donors and therefore, a significant general trend was
obtained. However, the osteogenic differentiation capacity deter-
mined by dexamethasone-induced ALP expression, mineralization
and in vivo bone formation did not correlate in any way.
Since the correlation obtained was only mildly significant, in
order to find a better marker for aging, we have generated a high-
resolution transcriptional profile of aging in human mesenchymal
stromal cells using a large sample size of 61 donors, with ages
ranging from 17–84 years. Previously, the effect of in vitro
senescence was investigated on different hMSC populations
derived from one young donor (15 years old) [22]. In this study,
the authors identified 338 genes related to in vitro senescence.
Interestingly, 6 genes overlapped with our top 70 list correlating to
in vivo aging: CDH13, ZNF 365, ANKRD1 (ankyrin repeat domain 1
(cardiac muscle), COLEC12, INSIG1 (insulin induced gene 1) and
CDH6 (cadherin 6, type 2, K-cadherin (fetal kidney)). In contrast,
the observed down regulation of KRT18 in vitro could not be
confirmed, this gene was positively correlated with age in our
dataset. Furthermore, another gene expression profiling study on
hMSCs has been previously performed, however, on a limited
donor population (young, median aged and elderly donors, n = 4
per group) [23]. Their analysis revealed 184 genes correlating with
age, of which, only S100A4 is present in our list. Although HOXB7
and SHOX2 were present in our initial list as well, similar to their
results, the expression significantly correlated with the aspiration
site of bone marrow in our study. Our work provides, however, a
significantly larger sample size which enables a higher statistical
resolution and further evaluates the relation between donor age
and MSC differentiation capacity, compares the expression of the
Figure 2. Correlation between biological parameters and
donor age. A correlation between age and clinical and biological
labels could not be determined for labels such as A) population
doublings per day between day 0–1 and bone formation. Correlation
with donor age could solely be determined for B) the mean ALP
expression and C) the percentage ALP positive cells in basic medium.
doi:10.1371/journal.pone.0042908.g002
Table 1. Pearson correlation of biological characteristics with
donor age.
Characteristic R Sig.
Yield (mL) 0.167 0.198
Number of nucleated cells per ml 20,178 0,170
Population doublings, day 0–1 20.193 0.135
Population doublings, day 1–2 20.621 0.074
Bone formation 0.033 0.799
Percentage of bone compared to scaffold 0.105 0.420
Percentage of bone contact 0.097 0.458
* Mean ALP expression (control) 20.315 0.045
Mean ALP expression (dex) 20.299 0.057
Mean ALP expression (index) 20.167 0.297
* Percentage ALP positive cells (control) 20.353 0.023
Percentage ALP positive cells (dex) 20.217 0.174
Percentage ALP positive cells (index) 20.143 0.372
Mineralization 20.129 0.587
Adipogenesis 20.131 0.570
Cartilage formation (GAG/DNA) 0.423 0.063
*represents p,0.05.
doi:10.1371/journal.pone.0042908.t001
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markers obtained by the gene expression profiles with in vitro
replicative senescence and assesses whether the same markers can
predict the chronological age also in animal models (Wistar rats).
Other studies have focused on the characterization of tissue-
specific gene expression profiles such as: human brain [17], human
muscle [18] or human kidney [19]. Similar studies have also been
done in a large Epstein-barr virus-immortalized lymphoblastoid
cell line bank (46 three-generation families) [24] and in multiple
mouse strains [25].
The main advantage of our work is that a whole genome-wide
gene expression profiling was performed in a large sample size of
untransformed hMSCs (61 donors) and since it was performed on
human MSCs, it allowed us to obtain general markers for aging
rather than tissue-specific ones, which are more prone to present
higher donor variation due to external factors since in our study
the co-founder effects can be more easily evaluated. While some
patterns of aging are similar between human tissues, much of it is
tissue specific [18].
Table 2. List of genes correlating in hMSCs with donor age (p,0.01) based on ANOVA.
Official symbold p-valuea FDRb FCc Official symbol p-value FDR FC
1 SLIT3 0.00002 0.03306 20.017 36 PDE4DIP 0.00279 0.12288 20.013
2 FST 0.00009 0.03967 0.019 37 JAG1 0.00279 0.12288 0.016
3 FGFR2 0.00011 0.03967 20.016 38 COL13A1 0.00290 0.12288 0.016
4 NDNF 0.00012 0.03967 20.024 39 CXCL12 0.00290 0.12288 20.012
5 NDNF 0.00012 0.03967 20.016 40 SOX4 0.00301 0.12440 20.012
6 FGFR2 0.00025 0.06887 20.013 41 ESM1 0.00334 0.13160 0.018
7 COLEC12 0.00041 0.08430 20.031 42 IGF2BP3 0.00334 0.13160 0.011
8 C1R 0.00042 0.08430 20.017 43 SLC1A3 0.00372 0.13529 20.015
9 TFPI 0.00050 0.08430 0.014 44 CDH13 0.00372 0.13529 0.013
10 FST 0.00051 0.08430 0.014 45 LIF 0.00372 0.13529 0.017
11 FZD1 0.00059 0.08887 20.013 46 C21orf7 0.00387 0.13529 0.020
12 OLFML3 0.00087 0.10631 20.015 47 GLIPR1 0.00387 0.13529 0.012
13 RGS4 0.00097 0.10631 0.034 48 TFPI2 0.00401 0.13529 0.018
14 NRXN3 0.00097 0.10631 0.017 49 WISP1 0.00401 0.13529 20.015
15 CH25H 0.00105 0.10631 20.029 50 NRN1 0.00451 0.14912 20.013
16 MATN2 0.00105 0.10631 20.014 51 GLIPR1 0.00521 0.16564 0.013
17 MGLL 0.00109 0.10631 0.011 52 HMGA2 0.00521 0.16564 0.010
18 BDNF 0.00131 0.11535 0.013 53 MALL 0.00541 0.16564 0.015
19 PTX3 0.00133 0.11535 0.023 54 NR2F2 0.00541 0.16564 0.014
20 ANKRD1 0.00140 0.11562 0.017 55 COL10A1 0.00561 0.16864 20.019
21 TFPI 0.00154 0.11855 0.020 56 DDIT4 0.00581 0.17153 20.020
22 TFPI 0.00174 0.11855 0.020 57 CDH6 0.00601 0.17432 0.017
23 CDH6 0.00180 0.11855 0.026 58 OSR2 0.00621 0.17702 0.012
24 RGS4 0.00187 0.11855 0.034 59 INSIG1 0.00641 0.17962 20.012
25 MOXD1 0.00193 0.11855 0.016 60 GAS1 0.00701 0.19001 20.019
26 MAFB 0.00193 0.11855 20.018 61 ANK3 0.00701 0.19001 0.013
27 FOSL2 0.00194 0.11855 20.015 62 CXCR7 0.00751 0.20027 20.011
28 GPR116 0.00209 0.11855 0.013 63 DKK1 0.00776 0.20366 0.022
29 JAG1 0.00209 0.11855 0.017 64 ID2 0.00826 0.20903 20.011
30 KRT18 0.00218 0.11855 0.033 65 MAFF 0.00835 0.20903 0.011
31 TNFRSF21 0.00237 0.11855 0.020 66 TNFAIP3 0.00835 0.20903 0.010
32 ZNF365 0.00237 0.11855 0.011 67 GATA6 0.00901 0.22236 0.019
33 FMO3 0.00243 0.11855 0.028 68 PSG4 0.00935 0.22391 0.011
34 B3GALT2 0.00246 0.11855 0.013 69 C1S 0.00935 0.22391 20.008
35 FMO3 0.00251 0.11855 0.025 70 FADS1 0.00968 0.22858 20.012
a: p values for genes correlating with age corrected for the confounding effects attributed to the sex of the donor and the aspiration site of the bone marrow. The p
values were computed omitting the samples with unknown origin.
b: FDR = the false discovery rate.
c: The slope corresponds to the strength of the correlation. This value can be considered as the fold change per year. (i.e. 0.017 corresponds to a fold change of 1,7 per
100 years).
d: The genes presented in bold are affected by the aspiration site of the bone marrow (acetabulum or iliac crest) (p,0.01).
doi:10.1371/journal.pone.0042908.t002
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Furthermore, examination of the gene ontology (GO) terms on
the top 70 gene list revealed an overrepresentation of GO terms
related to neuronal functioning. Furthermore, more general terms
were enriched like growth factor activity and located in the
extracellular region. A number of genes could be linked to hMSC
function or aging. FGFR2 is targeted by bFGF and positively
regulates osteogenic differentiation [26] and as expected, FGFR2
expression declines with donor age. Ankyrin 3 (ANK3) is
overexpressed in cells with the progeroid syndrome Hutchinson-
Gilford [27], which is supported by the increase of gene expression
with donor age in our research. The expression of JAG1, part of
the Notch signaling pathway and essential for the regeneration of
Table 3. GO Enrichment analysis with enrichment for all three GO categories.
Term Name FEa P value Countsb
Biological Process
GO:0007411 Axon guidance 10.35 1.12E-04 6
GO:0048667 Cell morphogenesis involved in neuron differentiation 5.31 1.19E-03 7
GO:0065007 Biological regulation 1.32 3.12E-03 42
GO:0000904 Cell morphogenesis involved in differentiation 4.43 3.26E-03 7
GO:0030182 Neuron differentiation 3.35 3.38E-03 9
GO:0048666 Neuron development 3.70 3.79E-03 8
GO:0022008 Neurogenesis 2.68 4.80E-03 11
GO:0007409 Axonogenesis 4.95 5.05E-03 6
GO:0032502 Developmental process 1.52 5.27E-03 29
GO:0048699 Generation of neurons 2.75 6.76E-03 10
Molecular Function
GO:0008083 Growth factor activity 4.61 0.007009 6
GO:0005509 Calcium ion binding 1.85 0.074216 10
GO:0016705 Oxidoreductase activity, acting on paired donors, with incorporation or
reduction of molecular oxygen
3.84 0.077651 4
GO:0004871 Signal transducer activity 1.61 0.099857 12
GO:0060089 Molecular transducer activity 1.61 0.099857 12
Cellular Component
GO:0005576 Extracellular region 2.03 3.13E-04 24
The GO term and name are given, along with the total number of genes correlating with age in the category and fold enrichment (FE) of the GO term. For each GO
category, the enriched categories or the top 10 is presented.
aFold Enrichment of the GO term in the top list of genes (p,0.01; as shown in Table 2).
bNumber of genes.
doi:10.1371/journal.pone.0042908.t003
Table 4. Gene expression validated with qPCR in 20 donors.
Official symbol Position (ANOVA Table 2) qPCR-validation P value qPCR-validation R**
AUTS2 - 0.194 20.303
* COL13A1 38 0.006 0.595
* COLEC12 7 0.044 20.454
CCNG2 - 0.214 20.291
DLK1 - 0.219 0.288
# FGFR2 3, 6 0.055 20.435
* FST 2, 10 0.006 0.593
HOXB7 (181) 0.942 0.017
* JAG1 29, 37 0.006 0.593
JAG2 - 0.507 0.158
# SLIT3 1 0.088 20.392
* ZNF395 - 0.004 20.617
*represents p,0.05.
**R is the Pearson correlation value with donor age.
#validated on 61 donors (p,0.05) (Figure 3).
doi:10.1371/journal.pone.0042908.t004
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muscle, is impaired in aged human muscle tissue [28]. In addition,
JAG1 enhances the potential of MSCs to differentiate into
cardiomyocytes [29]. We expected JAG1 expression to decrease
with donor age, however, our results prove the contrary,
suggesting a different function for Notch signaling in MSCs
compared to muscle. Notch receptors are however, known to
regulate cell fate determination, stem cell self-renewal, prolifera-
tion and apoptosis and JAG1 was previously associated with a poor
prognosis for breast cancer patients [30]. Therefore, it could be
associated with the increased chance of cancer occurrence in
elderly patients.
The aspiration site correlates significantly with donor age
(correlation value = 0.4103 and p-value = 0.0021). This variable
was considered, together with donor sex, as confounding factor in
the ANOVA model. The genes listed in Table 2, with a correlation
p value,0.01, were tested on their correlation between aspiration
site and donor age. Eleven genes from this list were significantly
affected by the aspiration site, which could not be proven for the
other genes in the list. Nevertheless, the correlation between the
listed genes and donor age could in many cases be observed for
both aspiration sites individually (data not presented). Further-
more, the dataset was filtered based on standard deviation over all
donors in order to limit the data to probe sets with larger effect
sizes. Some genes that correlated with donor age in an initial gene
list, were filtered out due to their low effect size. For example,
ZNF395, included in the validation qPCR, showed a low but
significant correlation (Figure 3G) while this gene was filtered out
by the adjusted analysis method. Some genes occur more often in
the top 70 probe-set list, making them more powerful indicators
for donor age. Moreover, false positive rates were calculated,
showing that the number of false positive probes that can be
expected is relatively limited. qPCR validation confirmed our
microarray analysis as a reliable method for gene expression
studies. Moreover, we have shown that FST is also differently
expressed during age in rat MSCs, indicating it as a possible inter-
species marker for age. FST has first been identified as an indirect
Figure 3. qPCR validation on the whole donor population. Correlation curves were produced for the expression of A) COLEC12, B) COL13A1, C)
FGFR2, D) FST, E) JAG1, F) SLIT3 and G) ZNF395 in the entire donor population and significant correlations could be confirmed.
doi:10.1371/journal.pone.0042908.g003
Figure 4. Gene-expression correlated to in vitro aging. The trend observed in relation to in vivo aging could not be confirmed in hMSCs aged
in vitro. Gene-expression was determined up to passage 7 in three donors (D.024: female, 59 years, acetabulum; D.036: female, 38 years, iliac crest;
D.118A: male, 60 years, acetabulum), however a general trend could not be observed. For some genes the expression pattern was random, A)
COL13A1 and D) ZNF395, and for other genes there seemed to be a trend in one of the donors, but this could not be confirmed in the other two, B)
FST and C) JAG1.
doi:10.1371/journal.pone.0042908.g004
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regulator of follicle-stimulating hormone secretion by binding
irreversibly to activin and thus inactivating it. Klein et al. have
shown that FST concentrations in follicular fluids from older
female subjects (40–45 year) were significantly higher compared to
younger female subjects (20–25 year) [31]. Furthermore, FST is
known to bind to myostatin. Increasing FST levels are also
identified in muscle biopsies from older male subjects [32]; this
effect could be counteracted by eccentric exercise [33]. This might
be due to increases in myostatin levels associated with muscle fiber
atrophy, although this could not be confirmed in our assay.
Additionally, FST has been identified as both a stimulator [34]
and inhibitor of bone mineralization [35]. A recent study in mice
demonstrated potential consequences of the increased levels of
FST with age; overexpression of FST led to reduced mechanical
properties of bone and therefore increased the susceptibility to
fractures [36]. Altogether, FST has the potential to regulate aging
in multiple tissue types.
Despite it was reported that several MSC age-related gene
expression changes (especially genes involved in genomic integrity
and regulation of transcription that were age-repressed) were also
differentially expressed during in vitro senescence [22,23], we
haven’t seen the same in our study. Our aging markers do not
apply to in vitro senescence since no correlation was found amongst
the three donors tested. Similar results were obtained previously
where it has been shown that the expression signature of in vitro
senescence resembled mouse but not human aging [37].
Our results showed a large donor variation in gene expression
during in vitro replicative senescence and therefore, suggested that
data obtained in vitro might not be entirely correlated with what
happens in vivo. Although both intrinsic and extrinsic factors might
contribute for in vitro senescence, it is likely that the adverse culture
conditions influence more the in vitro senescence process,
presumably making hMSCs more exposed to DNA damage than
they would face in vivo.
In this study we were able to identify genes that significantly
correlated with donor age, suggesting that stem cells are also
influenced by the aging process. Interestingly, we have observed a
remarkably small effect of donor age on the biological character-
istics tested (Table 1), which shows that MSCs from the bone
marrow seem to maintain their quality with aging. This is in
agreement with the hypothesized fact that stem cells themselves
seem to be protected from aging due to their mostly quiescence
status, however, in contradiction with the studies on aging
hematopoietic stem cells (HSCs) where it was demonstrated that
although the repopulation ability of HSCs from young versus old
follow the same time frame, some months after transplantation the
contributions from the old HSCs drop considerably, which
suggests that aging HSCs lose their repopulating capacity [38].
If there are some disparities between HSC and MSC aging effects
on their quality and performance, little disagreement exists about
the fact that regenerative potential and body repair systems
deteriorate with age.
Another interesting aspect was the fact that there is a clear large
inter-donor variability present on MSCs from the same age, even
though aging itself has no clear effect on performance. Unfortu-
nately we do not have the disease history of the patients, so we
were not able to analyze if the potential orthopaedic disease
history might be of influence in the data analysis.
Our top list with genes correlating to in vivo donor aging, may
provide a window of opportunity to acquire more insight into the
molecular mechanisms behind human aging.
In conclusion, we have identified a set of genes which expression
in human MSCs correlates to donor age but not to in vitro
senescence. The presence in the list of genes known to be involved
in aging, demonstrates the biological relevance of the genes. The
new genes correlated to age unveiled in this manuscript may lead
the way to a better insight into the process of human MSC aging.
Materials and Methods
Isolation and culture of human mesenchymal stromal
cells
Bone marrow aspirates (5–20 ml) were obtained from donors
with written informed consent - for under aged donors legal
guardians were involved - and were approved by the medical
ethical committee of the University medical Centre Utrecht, and
hMSCs were isolated and proliferated as described previously
[39]. Briefly, aspirates were resuspended using a 20-gauge needle,
plated at a density of 500,000 nucleated cells/cm2 and cultured in
hMSC proliferation medium containing a-minimal essential
medium (a-MEM; Gibco), 10% fetal bovine serum (FBS; Biowhit-
taker, Australia), 0.2 mM ascorbic acid (Sigma), 2 mM L-
glutamine (Gibco), 100 U/mL penicillin with 100 mg/mL strep-
tomycin (Gibco) and 1 ng/mL basic fibroblast growth factor
(bFGF; Instruchemie, Delfzijl, The Netherlands). The serum batch
was selected on proliferation rate and osteogenic differentiation
potential and used for all experiments in this paper. Cells were
grown at 37uC in a humid atmosphere with 5% CO2. Medium
was first changed after 5 days to remove non-adherent cells and
was further refreshed twice a week. Cells were used for further
subculturing or cryopreservation upon reaching near confluence.
hMSC basic/control medium (BM) was composed of hMSC
proliferation medium without bFGF, hMSC osteogenic medium
was composed of hMSC basic medium supplemented with
1028 M dexamethasone (dex, Sigma). Basic medium was used as
a control. ALP expression was measured by flow cytometry as
described previously [40].
Isolation and culture of rat mesenchymal stromal cells
Rat MSCs were obtained as described previously [41]. Femora
of 1, 12 and 24 months old male rats (Male Crl:WI(Han), Charles
River, n = 3) were removed, thoroughly cleaned and submerged in
PBS containing 250 mg/ml Fungizone (Invitrogen). After removal
of the epiphyses, the bone marrow was flushed out with 10 ml of
rat MSC proliferation medium containing a-MEM (Gibco), 15%
Figure 5. Validation of gene-expression in rat MSCs. To assess if
age-related gene-expression was similar inter-species, MSCs were
isolated from 1, 12 and 24 month old rats. The correlation between
the expression of follistatin and age could be verified in rat MSCs,
suggesting this is possibly a marker for several species. For the other
three genes no correlation was found.
doi:10.1371/journal.pone.0042908.g005
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FBS (Biowhittaker, Australia), 0.2 mM ascorbic acid (Sigma),
2 mM L-glutamine (Gibco), 100 U/mL penicillin with 100 mg/
mL streptomycin (Gibco) and 1 ng/mL bFGF (Instruchemie,
Delfzijl, The Netherlands) and cultured in T75 flasks. Cells were
grown at 37uC in a humid atmosphere with 5% CO2. Medium
was first changed after 3 days to remove non-adherent cells and
was further refreshed three times a week. Animals were housed at
the Central Laboratory for Animal Institute (Utrecht University,
Utrecht, The Netherlands), and experiments were approved by the
local animal care and use committee.
Microarray analysis
To analyze the gene expression profile of hMSCs, cells were
seeded at 1000 cells/cm2 and upon reaching near confluence
RNA was isolated using an RNeasy mini kit (Qiagen) and DNase
treated on column with 10 U RNase free DNase I (Gibco) at 37uC
for 30 minutes. DNase was inactivated at 72uC for 15 minutes.
The quality and quantity of RNA was analyzed by gel
electrophoresis and spectrophotometrically. The RNA was
hybridized to the Human Genome U133A 2.0 Array (Affymetrix)
and scanned with a GeneChip G3000 scanner (Affymetrix). The
microarray experiments were performed in three batches.
Although this was done at the same microarray facility using
arrays from the same production batch, there were still noticeable
batch effects. To normalize the measurements, we used a
normalization method which removes hybridization, amplification
and array location effects [42]. Afterwards, probe sets which did
not show significant differences in expression between arrays
(std,0.4) were removed. The remaining 1653 probe sets (out of
22,277 probe sets) were used for further analysis. To determine the
most significant probe sets with respect to age, we determined a p-
value for each gene by permuting F-test scores. In total, 105
permutations were performed for each gene. To adjust for
multiple testing, we calculated a false discovery rate. Microarray
data can be retrieved from the Gene Expression Omnibus (GEO)
at the National Center for Biotechnology Information (NCBI)
under the accession number GSE39540. Enriched biological terms
were identified by Gene ontology analyses on the genes correlating
with age (p,0.01; as presented in Table 2) using the Database for
Annotation, Visualization and Integrated Discovery (DAVID)
[43].
Quantitative polymerase chain reaction (qPCR)
To investigate gene expression, hMSCs were seeded at 1000
cells/cm2 and freshly isolated rat MSCs were used, upon reaching
near confluence RNA was isolated using an RNeasy mini kit
(Qiagen) and DNase treated on column with 10 U RNase free
DNase I (Gibco) at 37uC for 30 minutes. DNase was inactivated at
72uC for 15 minutes. The quality and quantity of RNA was
analyzed using gel electrophoresis and spectrophotometrically.
The iScript cDNA synthesis kit (Bio-rad) was used according to the
manufacturer’s protocol to synthesize first strand complementary
DNA (cDNA) from 1 mg RNA. qPCR was carried out on a iQTM5
Real-Time PCR Detection System (Bio-Rad) using 1 mL of 16,
106 or 1006 diluted cDNA, 500 nM forward primers, 500 nM
reverse primers, 26 iQ SYBR Green Supermix (Bio-rad). For the
gene expression analysis of AUTS2, DLK1 and JAG2, the forward
and reverse primers were substituted for 1 mL gene-specific RT2
qPCR Primers (SABiosciences). The remaining primer sequences
(Sigma) are depicted in Table 5, as a reference gene GAPDH was
used for hMSCs and b-actin for rat MSCs. Primer efficiencies
were determined and gene expression was calculated and
normalized to the average gene expression according to the
method of Pfaffl et al. [44].
Statistics
Regression analysis and Pearson correlations were used to
analyze correlations between donor age and biological parameters
and gene expression. Multiple regressions were used to exclude sex
and location of aspiration as confounding factors (Eq. 1) and to
analyze if the combinations of multiple genes gave a more accurate
description of the age of the donor (Eq. 2).
Acknowledgments
We are grateful to L. Creemers (UMC), W. Dhert (UMC) for kindly
providing us with bone marrow aspirates.
Table 5. qPCR primer sequences.
Gene name Forward primer (59-39) Reverse primer (59-39)
hGAPDH CGCTCTCTGCTCCTCCTGTT CCATGGTGTCTGAGCGATGT
hCOLEC12 ACTCAGAGCGTGAAAATGAATGG CCCAGCATAAATCAACCCAGC
hCOl13A1 TTGGATCCGGTCAACCAGGCACTAGAGGTTTCC TTGAATTCTTGGATGCTGGCCTGGCTCTGTTCG
hCCNG2 CCAACTTCTCGGGTTGTTGAACGTCTACC CTAATCCGGATCACATCATGAGTG
hFGFR2 GGCTGCCCTACCTCAAAGGTTC AGTCTGGGGAAGCTGTAATCTC
hFST AGGAGGACGTGAATGACAACA CCAACCTTGAAATCCCATAAA
hHOXB7 AGAGTAACTTCCGGATCTA TCTGCTTCAGCCCTGTCTT
hJAG1 AGGCCGTTGCTGACTTAGAA GCAGAAGTGGGAGCTCAAAG
hSLIT3 CCGCCTAACTACACAGGTGAGCTAT CGCTGTAGCCAGGGACACACT
hZNF395 AGAGTCTGGGGCTGTGTGTT ATGGTCCTTTTGCTTTGCAC
rb-actin TTCAACACCCCAGCCATGT TGTGGTACGACCAGAGGCATAC
rCOL13A1 ACCGGGGGCCTCTGGGATT GGCAGGGGGCGTCTAGTCCA
rFST CGGCTGAGCACCTCGTGGAC TCGGCACTTTTTCCCGGGGC
rJAG1 GGTGTGGCCCGAGACCTTGC GCTGGAGGCTGGAGGACCGA
rZNF395 CTGTGTGCCAGGAGCAGCCC CTGCTCCACCAGGCCCTTGC
doi:10.1371/journal.pone.0042908.t005
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